Perampanel Suspension
Product Images NDC 72205-071

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Perampanel (NDC 72205-071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Peram-oral-sus-carton-label (Peram Oral Sus Carton Label)

Peram-oral-sus-carton-label (Peram Oral Sus Carton Label)
Perampanel Oral Suspension 0.5 mg/mL carton label for oral administration, containing 340 mL. The label states Rx only and includes instructions to dispense the accompanying Medication Guide to each patient. It is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. The label also notes to discard unused portions 90 days after first opening and to store below 30°C (86°F), with a warning not to freeze.*
FDA Label Image

Peram-oral-sus-cntr-label (Peram Oral Sus Cntr Label)

Peram-oral-sus-cntr-label (Peram Oral Sus Cntr Label)
Label for Perampanel Oral Suspension 0.5 mg/mL by Novadoz Pharmaceuticals LLC. The label indicates the product is for oral administration, requiring shaking before use, and comes in a 340 mL bottle. It includes storage instructions, a note to dispense the medication guide, and manufacturing details by MSN Pharmaceuticals Inc. in Piscataway, NJ.*
FDA Label Image

Peram-oral-sus-fig-01 (Peram Oral Sus Fig 01)

Peram-oral-sus-fig-01 (Peram Oral Sus Fig 01)
A bar chart showing median percentage seizure reduction from baseline across three studies comparing placebo and Perampanel treatment at various mg/day doses. Bars indicate higher seizure reduction percentages for Perampanel versus placebo, with statistical significance noted. The horizontal axis shows different study groups and doses; the vertical axis shows percentage reduction up to 50%.*
FDA Label Image

Peram-oral-sus-fig-02 (Peram Oral Sus Fig 02)

Peram-oral-sus-fig-02 (Peram Oral Sus Fig 02)
A bar chart showing the proportion of patients (%) across different outcome categories for Perampanel oral suspension at doses of 4 mg/day, 8 mg/day, and 12 mg/day compared to placebo. The categories range from 'Worse' to '75 to <100', indicating relative patient responses in a clinical study.*
FDA Label Image

Peram-oral-sus-fig-03 (Peram Oral Sus Fig 03)

Peram-oral-sus-fig-03 (Peram Oral Sus Fig 03)
A bar chart comparing the proportion of patients (%) across different response categories between placebo and Perampanel treatment groups. The x-axis represents response ranges from 'Worse' through '0 to <25', '25 to <50', '50 to <75', to '75 to 100', and the y-axis shows the proportion of patients. Bars indicate patient distribution for each category in both placebo and Perampanel groups, with Perampanel showing a notably higher proportion in the '75 to 100' response range.*
FDA Label Image

Peram-oral-sus-fig-a (Peram Oral Sus Fig A)

Peram-oral-sus-fig-a (Peram Oral Sus Fig A)
An instructional diagram showing a bottle, box, and bottle adapter alongside a syringe filled with purple liquid dosed up to 20 mL. The syringe components are labeled: tip, barrel, dosage indicators on the side, and plunger. The diagram visually explains parts and measurement markings on the syringe for accurate dosing.*
FDA Label Image

Peram-oral-sus-fig-b (Peram Oral Sus Fig B)

Peram-oral-sus-fig-b (Peram Oral Sus Fig B)
An instructional illustration showing a hand holding a bottle of PERAMPANEL oral suspension. Arrows next to the bottle indicate a shaking motion, with the instruction 'shake well' to ensure the medication is properly mixed before use.*
FDA Label Image

Peram-oral-sus-fig-c (Peram Oral Sus Fig C)

Peram-oral-sus-fig-c (Peram Oral Sus Fig C)
An illustration showing a bottle adapter component used for dispensing liquid medication. The image includes a labeled depiction highlighting the bottle adapter's shape and design for use with a suspension product.*
FDA Label Image

Peram-oral-sus-fig-d (Peram Oral Sus Fig D)

Peram-oral-sus-fig-d (Peram Oral Sus Fig D)
An instructional illustration showing a hand holding an oral suspension bottle with an arrow pointing downward, indicating the action to press or push the cap down, likely part of directions for opening or securing the bottle cap.*
FDA Label Image

Peram-oral-sus-fig-e (Peram Oral Sus Fig E)

Peram-oral-sus-fig-e (Peram Oral Sus Fig E)
An instructional diagram of an oral dosing syringe for measuring liquid medication. The syringe is labeled with parts including tip, barrel, plunger, and dosage indicators marked in milliliters (mL) from 1 mL to 20 mL. There is a magnified view showing the dosage scale in detail.*
FDA Label Image

Peram-oral-sus-fig-f (Peram Oral Sus Fig F)

Peram-oral-sus-fig-f (Peram Oral Sus Fig F)
An instructional illustration showing a hand holding a bottle and another hand holding a syringe above the bottle, indicating the syringe is being filled or used with the bottle contents. The syringe is marked with measurement lines and is colored purple to highlight it.*
FDA Label Image

Peram-oral-sus-fig-g (Peram Oral Sus Fig G)

Peram-oral-sus-fig-g (Peram Oral Sus Fig G)
An instructional illustration showing a hand holding a medication bottle upside down and dispensing a pink liquid suspension into a syringe, while another hand stabilizes the syringe tip. This depicts withdrawal of oral suspension medication using a dosing syringe.*
FDA Label Image

Peram-oral-sus-fig-h (Peram Oral Sus Fig H)

Peram-oral-sus-fig-h (Peram Oral Sus Fig H)
Illustration showing a hand drawing liquid medication from a bottle using an oral syringe. The bottle is held steady by the other hand, and an upward arrow indicates the syringe being pulled upward to measure the dose, consistent with preparation for administration of oral suspension.*
FDA Label Image

Peram-oral-sus-fig-i (Peram Oral Sus Fig I)

Peram-oral-sus-fig-i (Peram Oral Sus Fig I)
An instructional illustration showing a person administering an oral medication suspension to a child using a measuring syringe.*
FDA Label Image

Peram-oral-sus-fig-j (Peram Oral Sus Fig J)

Peram-oral-sus-fig-j (Peram Oral Sus Fig J)
An instructional illustration showing a person using a purple oral dosing syringe to measure and administer medication. The left side depicts drawing liquid into the syringe from a container, and the right side shows dispensing the liquid by pressing down the syringe plunger over a drinking glass or a different container.*
FDA Label Image

Peram-oral-sus-fig-k (Peram Oral Sus Fig K)

Peram-oral-sus-fig-k (Peram Oral Sus Fig K)
An instructional illustration showing a hand removing a cap from a bottle, demonstrating how to open the packaging of an oral suspension.*
FDA Label Image

Peram-oral-sus-structure (Peram Oral Sus Structure)

Peram-oral-sus-structure (Peram Oral Sus Structure)
Chemical structure of Perampanel showing its molecular framework including pyridine and phenyl rings, a cyano group, and a lactam ring with associated water of hydration indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.